Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Puma Biotechnology Priced Like Takeover Target: Real M&A
Puma Biotechnology Priced Like Takeover Target: Real M&A
Puma Biotechnology Priced Like Takeover Target: Real M&A
Submitted by
admin
on March 12, 2013 - 11:26am
Source:
Bloomberg
News Tags:
Puma Biotechnology
M&A
AstraZeneca
Bristol-Myers Squibb
Takeda
Celgene
GSK
Headline:
Puma Biotechnology Priced Like Takeover Target: Real M&A
Do Not Allow Advertisers to Use My Personal information
